Gunda Georg

Health Sciences
Academic Health Center

Diabetes
From stem cells to surgical solutions, we search for treatments, preventions and cures for diabetes.
Infectious Diseases
Interdisciplinary research means more breakthroughs, as we study and prevent global health threats.
Neurosciences
From Alzheimer’s to movement disorders, we reduce the toll of brain diseases on patients and families.
Cancer
Basic science and clinical studies combine, as we increase survival rates of some of the most deadly cancers.
Cardiovascular Disorders
Pioneers in early heart surgery, we discover new techniques, medications and devices to heal hearts.

Home > Meet the AHC > Expert Guide > Gunda Georg

AHC - Image - Expert - Size C - Gunda Georg

Appointment

Professor and Head, Department of Medicinal Chemistry
Director, Institute for Therapeutics Discovery and Development
Robert Vince Endowed Chair and McKnight Presidential Chair

Expert Areas

Drug Design and Development, Pharmacy

Research Focus

A world-renowned medicinal chemist, Georg’s goals are to discover and develop bioactive compounds and to improve their potency, selectivity, and pharmaceutical properties. Georg’s research interests include cancer, male contraception, and Alzheimer's disease. Dr. Georg is a co-inventor of Lusedra, a commercial anestetic drug. She is also a co-inventor of Gamendazole, a male contraceptive agent, and Minnelide an anticancer agent, both which are undergoing preclinical development.